simvastatin has been researched along with Diathesis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Azadi, A; Azadi, S; Farjadian, F; Mohammadi Samani, S; Mozafari, N | 1 |
Labella Quesada, F; López-Muñoz, F; Povedano-Montero, FJ; Salado-Font, SM | 1 |
Bui, T; Jiang, X; Kocher, J; LeRoith, T; Li, G; Li, Y; Liu, F; Tan, M; Wen, K; Xia, M; Yang, X; Yuan, L; Zhong, W | 1 |
Chang, KO; Jung, K; Kim, Y; Saif, LJ; Scheuer, K; Shen, Q; Wang, Q; Zhang, Z | 1 |
4 other study(ies) available for simvastatin and Diathesis
Article | Year |
---|---|
Simvastatin-chitosan-citicoline conjugates nanoparticles as the co-delivery system in Alzheimer susceptible patients.
Topics: Alzheimer Disease; Chitosan; Cytidine Diphosphate Choline; Disease Susceptibility; Drug Carriers; Humans; Nanoparticles; Simvastatin | 2020 |
Bibliometric analysis of the scientific production as regards statin use for ophthalmological symptoms of myasthenia gravis.
Topics: Atorvastatin; Bibliometrics; Blepharoptosis; Causality; Diplopia; Disease Susceptibility; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myasthenia Gravis; Ophthalmology; Simvastatin | 2017 |
Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age.
Topics: Age Factors; Animals; Caliciviridae Infections; Disease Models, Animal; Disease Susceptibility; Genotype; Germ-Free Life; Humans; Hypolipidemic Agents; Intestines; Molecular Sequence Data; Norovirus; RNA, Viral; Sequence Analysis, DNA; Simvastatin; Swine; Viral Load | 2013 |
The effects of simvastatin or interferon-α on infectivity of human norovirus using a gnotobiotic pig model for the study of antivirals.
Topics: Animals; Antiviral Agents; Blood Group Antigens; Caliciviridae Infections; Cholesterol; Dendritic Cells; Disease Models, Animal; Disease Susceptibility; Enterocytes; Feces; Gene Expression Regulation; Germ-Free Life; Humans; Interferon Regulatory Factor-3; Interferon-alpha; Intestines; Macrophages; NF-kappa B; Norovirus; Phenotype; Receptors, LDL; Simvastatin; Sus scrofa; Toll-Like Receptor 3; Viral Load; Virus Replication; Virus Shedding | 2012 |